GlassScriptPhysician profile
Andrew James Thomas
NPI 1922340579
$7,071.27
in general payments reported to CMS, 2019-2025
13 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $233 · 2021: $1,673 · 2022: $2,556 · 2023: $871 · 2024: $445 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350 · Consulting Fee: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.35 |
| Consulting Fee | $405.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,410.11 | 2021-2024 | Clarifix Cryotherapy Device, Scopis Ent, Xpress Loprofile |
| Aerin Medical INC. | $1,487.67 | 2019-2025 | |
| Medtronic, INC. | $1,021.75 | 2021-2024 | Propel, Stealthstation S8 Platform, Nuvent |
| Medical Device Business Services, INC. | $937.72 | 2021 | |
| Intersect Ent, INC. | $459.89 | 2019-2020 | |
| Optinose US, INC. | $233.38 | 2019 | |
| Smith+Nephew, INC. | $179.99 | 2019 | |
| Depuy Synthes Sales INC. | $91.91 | 2025 | Matrixmandible |
| Boston Scientific Corporation | $79.32 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Angiodynamics, INC. | $75.41 | 2021 | |
| Xoran Technologies LLC | $49.57 | 2021 | |
| Ethicon US, LLC | $23.59 | 2019 | |
| Medtronic USA, INC. | $20.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.